Pliant Therapeutics Inc Working Capital to Net Assets Ratio
Pliant Therapeutics Inc working capital to net assets ratio. Pliant Therapeutics Inc (PLRX) has a Working Capital to Net Assets ratio of 99.8% as of June 2026. Working capital of $146.66 Million (current assets of $163.14 Million minus current liabilities of $16.48 Million) is measured against net assets of $146.93 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Pliant Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Pliant Therapeutics Inc (2017–2025)
Working capital to net assets ratio of Pliant Therapeutics Inc from 2017 to 2025. This chart shows how Pliant Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 99.8%, reflecting working capital of $146.66 Million against net assets of $146.93 Million USD. See Pliant Therapeutics Inc (PLRX) liquidity interval to measure how many days the company can operate on defensive assets alone.
Pliant Therapeutics Inc Working Capital to Net Assets Ratio by Year (2017–2025)
Pliant Therapeutics Inc working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Pliant Therapeutics Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Pliant Therapeutics Inc balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.4% | $180.08 Million | $181.21 Million | $196.45 Million | $16.36 Million | ▼ -8.8 pp |
| 2024 | 108.2% | $329.05 Million | $304.08 Million | $362.26 Million | $33.22 Million | ▲ +7.5 pp |
| 2023 | 100.7% | $476.98 Million | $473.58 Million | $505.50 Million | $28.52 Million | ▼ -0.3 pp |
| 2022 | 101.0% | $316.40 Million | $313.34 Million | $340.31 Million | $23.91 Million | ▲ +4.2 pp |
| 2021 | 96.8% | $192.61 Million | $199.06 Million | $209.44 Million | $16.83 Million | ▼ -1.9 pp |
| 2020 | 98.6% | $279.15 Million | $283.06 Million | $290.75 Million | $11.60 Million | ▲ +23944.1 pp |
| 2019 | -23845.5% | $103.73 Million | $-435.00K | $111.90 Million | $8.17 Million | ▼ -17422.7 pp |
| 2018 | -6422.8% | $56.65 Million | $-882.00K | $61.73 Million | $5.08 Million | ▼ -6467.9 pp |
| 2017 | 45.1% | $1.52 Million | $3.37 Million | $4.71 Million | $3.19 Million | — |